Serpin E1/PAI-1 Antibody - BSA Free

Immunocytochemistry/ Immunofluorescence: Serpin E1/PAI-1 Antibody - BSA Free [NBP1-19773]

Immunocytochemistry/Immunofluorescence: Serpin E1/PAI-1 Antibody [NBP1-19773] - PAI1/Serpine1 antibody was tested in Hela cells with DyLight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).

Western Blot: Serpin E1/PAI-1 AntibodyBSA Free [NBP1-19773]

Western Blot: Serpin E1/PAI-1 Antibody - BSA Free [NBP1-19773] - Serpin E1/PAI-1 Antibody [NBP1-19773] - Immunoblots showing protein expression of pVHL, ALK5, pSMAD2/3, PAI-1, andI2-actin after transfection of indicated vectors in A498 cells followed by TGF-i2 treatment for 6 hours. Image collected and cropped by Citeab from the following publication (VHL status regulates transforming growth factor-B signaling pathways in renal cell carcinoma. Oncotarget (2018)) licensed under a CC-BY license.

Western Blot: Serpin E1/PAI-1 Antibody - BSA Free [NBP1-19773] -

Western Blot: Serpin E1/PAI-1 Antibody - BSA Free [NBP1-19773] - (A) Immunoblots showing protein expression of ALK5, pSMAD2/3, PAI-1, pVHL, & beta-actin in A498 cells after treatment with TGF-beta at given point of time; (B) Immunoblots showing protein expression of ALK5, pSMAD2/3, PAI-1, pVHL, & beta-actin in ACHN cells after treatment with TGF-beta at given point of time; (C) Immunoblots showing protein expression of pVHL, ALK5, pSMAD2/3, PAI-1, & beta-actin after transfection of indicated vectors in A498 cells followed by TGF-beta treatment for 6 hours; (D) Immunoblots showing protein expression of pVHL, HA, pSMAD2/3, PAI-1, & beta-actin after transfection of indicated vectors in ACHN cells (48h) followed by TGF-beta treatment for 6 hours; (E) Invasion assay showing the invasiveness induced by TGF-beta in A498 cells after re-introduction of VHL (n=3 independent experiments *P< 0. 05); (F) Invasion assay showing invasiveness by TGF-beta in ACHN cells after siRNA VHL knockdown (n=3 independent experiments *P< 0.05). Image collected & cropped by CiteAb from the following publication (https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.24631), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: Serpin E1/PAI-1 Antibody - BSA Free [NBP1-19773] -

Western Blot: Serpin E1/PAI-1 Antibody - BSA Free [NBP1-19773] - (A) Immunoblots showing protein expression of ALK5, pSMAD2/3, PAI-1, pVHL, & beta-actin in A498 cells after treatment with TGF-beta at given point of time; (B) Immunoblots showing protein expression of ALK5, pSMAD2/3, PAI-1, pVHL, & beta-actin in ACHN cells after treatment with TGF-beta at given point of time; (C) Immunoblots showing protein expression of pVHL, ALK5, pSMAD2/3, PAI-1, & beta-actin after transfection of indicated vectors in A498 cells followed by TGF-beta treatment for 6 hours; (D) Immunoblots showing protein expression of pVHL, HA, pSMAD2/3, PAI-1, & beta-actin after transfection of indicated vectors in ACHN cells (48h) followed by TGF-beta treatment for 6 hours; (E) Invasion assay showing the invasiveness induced by TGF-beta in A498 cells after re-introduction of VHL (n=3 independent experiments *P< 0. 05); (F) Invasion assay showing invasiveness by TGF-beta in ACHN cells after siRNA VHL knockdown (n=3 independent experiments *P< 0.05). Image collected & cropped by CiteAb from the following publication (https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.24631), licensed under a CC-BY license. Not internally tested by Novus Biologicals.